They were profitable in 2017/18, went into the red for 18/19 and I suspect will still be in the red, but with greater revenues in 19/20 but 20/21 will be back in the black. Our product mix will have stabilised cost reductions will be put in place and we’ll have higher margin supplements for sale in Aust and China. They’ve got the products and the infrastructure to make this happen, it’ just taxes time.
You make it sound like they’ve been in the red for eons. That isn’t the case.
- Forums
- ASX - By Stock
- OJC
- Ann: AGM Address to Shareholders
Ann: AGM Address to Shareholders, page-20
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OJC (ASX) to my watchlist
(20min delay)
|
|||||
Last
18.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $53.32M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
OJC (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online